Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

New Jersey-based Dr Reddy's Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VZvxFq7
via IFTTT